Medpace Holdings, Inc. logo
Medpace Holdings, Inc. (MEDP)
Compare

MEDP Balance Sheet

Assets, liabilities, and equity analysis

MEDP Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
1.139B1.139B989.624M737.285M520.805M821.437M1.029B1.033B872.523M
652.681M652.681M497.049M285.351M46.330M441.436M669.436M656.900M510.894M
Short-Term Investments
0.000.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
652.681M652.681M497.049M285.351M46.330M441.436M669.436M656.900M510.894M
394.581M394.581M402.078M373.034M377.921M298.217M296.443M311.466M301.108M
0.000.000.000.000.000.000.000.000.00
2.130B2.130B1.975B1.753B1.572B1.897B2.101B2.084B1.920B
263.360M263.360M248.870M256.761M264.985M258.191M252.264M254.605M256.395M
662.396M662.396M662.396M662.396M662.396M662.396M662.396M662.396M662.396M
Intangible Assets
33.265M33.265M33.420M33.657M33.893M34.130M34.366M34.727M35.087M
Long-Term Investments
0.000.000.000.000.000.000.000.000.00
Total Current Liabilities
1.345B1.345B1.344B1.284B1.220B1.122B1.105B1.041B993.088M
34.429M34.429M28.142M26.523M43.275M61.318M32.528M26.201M27.388M
0.000.0023.209M24.906M24.886M0.000.000.000.00
Total Liabilities
1.531B1.531B1.516B1.459B1.399B1.304B1.275B1.203B1.156B
0.000.00113.643M0.000.000.000.000.000.00
122.256M122.256M250.495M143.973M149.832M126.660M126.234M128.277M131.796M
Net Debt (Cash)
-530.425M-530.425M-246.554M-141.378M103.502M-314.776M-543.202M-528.623M-379.098M
598.314M598.314M459.071M293.641M172.351M593.609M825.545M881.439M763.599M
Common Stock
286K286K284K282K281K298K306K311K310K
-336.111M-336.111M-459.981M-596.237M-703.215M-269.716M8.167M65.636M-30.790M
0.850.850.740.570.430.730.930.990.88
0.200.200.550.490.870.210.150.150.17

MEDP Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
989.624M1.029B593.828M333.962M690.912M473.651M317.028M178.114M
497.049M669.436M245.449M28.265M461.304M277.766M131.920M23.275M
Short-Term Investments
0.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
497.049M669.436M245.449M28.265M461.304M277.766M131.920M23.275M
402.078M296.443M298.400M253.404M186.432M160.962M155.662M133.449M
0.000.000.000.000.000.000.007K
1.975B2.101B1.657B1.352B1.660B1.391B1.143B967.933M
248.870M252.264M265.390M248.917M222.711M198.826M99.444M52.255M
662.396M662.396M662.396M662.396M662.396M662.396M662.396M660.981M
Intangible Assets
33.420M34.366M35.809M38.008M41.360M46.474M54.350M69.179M
Long-Term Investments
0.000.000.000.000.000.000.000.00
Total Current Liabilities
1.344B1.105B925.131M803.470M557.217M440.110M343.002M257.026M
28.142M32.528M31.869M33.069M25.678M26.552M22.404M16.737M
23.209M23.289M0.0050.000M0.000.000.000.00
Total Liabilities
1.516B1.275B1.098B966.108M707.007M584.898M416.788M378.230M
113.643M0.000.000.000.000.000.0079.721M
250.495M149.523M142.122M188.867M130.965M115.143M45.212M79.721M
Net Debt (Cash)
-246.554M-519.913M-103.327M160.602M-330.339M-162.623M-86.708M56.446M
459.071M825.545M558.950M386.387M952.928M805.779M726.283M589.703M
Common Stock
284K306K308K309K360K355K360K356K
-459.981M8.167M-221.645M-359.827M234.984M115.229M68.109M-41.487M
0.740.930.640.421.241.080.920.69
0.550.180.250.490.140.140.060.14

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH
5,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle